KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 11 filers reported holding KAZIA THERAPEUTICS LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $368,000 | +60.0% | 32,435 | -15.6% | 0.04% | +7.1% |
Q3 2020 | $230,000 | +113.0% | 38,435 | +18.5% | 0.04% | +82.6% |
Q2 2020 | $108,000 | +17.4% | 32,435 | 0.0% | 0.02% | +4.5% |
Q1 2020 | $92,000 | -35.2% | 32,435 | 0.0% | 0.02% | -24.1% |
Q4 2019 | $142,000 | +47.9% | 32,435 | 0.0% | 0.03% | +38.1% |
Q3 2019 | $96,000 | – | 32,435 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UBS Group AG | 960 | $5,000 | 0.00% |
AdvisorNet Financial, Inc | 5 | $0 | 0.00% |
BREWIN DOLPHIN LTD | 32 | $180 | 0.00% |
MORGAN STANLEY | 50,001 | $281,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 8,101 | $45,000 | 0.00% |
Renaissance Technologies | 34,325 | $193,000 | 0.00% |
ROYAL BANK OF CANADA | 1,250 | $7,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |